product
Anhui Cheer-Medicinae nostrae technologiae notioni integritatis, professionalismi ac lucri-vincendi evolutioni adhaerens fuit.
- apixaban media
- Lercanidipinum medium
- Rivaroxaban medium
- Sitagliptin
![Acidum aceticum, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester](http://cdn.globalso.com/cheerour/Acetic-acid-2-chloro-2-2-4-methoxyphenylhydrazinyl-1.png)
![5,6-Dihydro-3-(4-morpholinyl) -1-[4-(2-oxo-1-piperidinyl)phenyl]-2(1H)-pyridinone](http://cdn.globalso.com/cheerour/ads-1.png)
![1-(4-Methoxyphenyl) -7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine. -3-acidi carboxylici ethyl ester](http://cdn.globalso.com/cheerour/dads.png)
nostra consilia
Habemus positivum, fortes ad pugnandum, altum professionalem qualitatem et periti iuvenes turmas professionales
nuntium
- Bayer novum cor medicamento Vericiguat approbatur in Sinis
- Die 15 Aprilis 2022 gubernator Lecardipinum hydrochloridi anulum principale uno tempore confectum effectio et capacitas currentis productionis est mensis 5mt/.
- Die 18 mensis Ianuarii anno 2022 societas in novo empto officio aedificando (Hefei Park, Provincia Anhui), residentem scalam dilatavit et in constructione laboratorum collocavit.
- Die 12 Octobris 2021, turma nostra LXXXVII Sinae Internationalis Pharmaceuticae (Industriae) exhibitio in Wuhan participata est.
- Societas nostra in 2019 Nova Delhi International Materiae Rudis Pharmaceuticae Exhibitionis CPhI Indiae participata est
- Anhui Cheer-Our Medical participatum est in exhibitione 81 API in Nanjing
De nobis
Anhui Vincebus Medical technology-Our
progressioni notioni integritatis, professionalismi et lucri-vincere adhaerens fuit.Perge ut clientes domesticos et externos cum uberioribus qualitatibus, servitiis et solutionibus praebeant.
Habemus positivum, fortes ad pugnam, altam professionalem qualitatem et expertos iuvenum turmas professionales.Investigationem et progressionem pharmaceuticae API & intermedia intendunt, et in pharmaceutica industria catenae industriae pharmaceuticae operas constanter persequuntur.